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Abstract 
 
Ayurveda refers Mimusops elengi L. for the treatment of the diabetes. 
Considering the traditional claim of M. elengi in management of diabetes and 
the possible involvement of oxidative stress in pathogenesis of diabetes, the 
present study was aimed to evaluate the in vitro antioxidant and in vivo 
antihyperglycemic property of methanolic extract of bark of M. elengi 
(MEMeOH). In vitro antioxidant activity of MEMeOH was evaluated using 
reducing power assay, DPPH and hydroxyl radical scavenging assay. 
MEMeOH offered significant in vitro reducing power capacity and radical 
scavenging activity. In acute study in alloxan induced diabetes, MEMeOH 
exhibited significant (p< 0.001) antihyperglycemic effect. The onset of 
antihyperglycemic effect was observed at 2nd hr; peak activity was 
demonstrated at 6th hr. The antihyperglycemic effect of MEMeOH 400mg/kg, 
p.o. was persistent up to 24th hr after drug administration. MEMeOH 
produced significant (p < 0.01) reduction in elevated glucose levels in 
glucose loaded non diabetic animals. The onset of action in non diabetic oral 
glucose tolerance test was found to be at 60th min and peak activity was 
observed at 120th min after oral glucose load. MEMeOH demonstrated 
significant (p < 0.01) reduction in elevated glucose levels 2hr before glucose 
administration and 6 hr after glucose load in oral glucose tolerance test in 
diabetic animals. MEMeOH has demonstrated antihyperglycemic activity in 
diabetic as well as non diabetic glucose loaded mice. MEMeOH should be 
further explored against diabetes and related complications. 
Keywords: Mimusops elengi; antihyperglycemic, antioxidant, DPPH, 
diabetic OGTT 
 
Introduction 
Diabetes mellitus is a chronic incurable condition 
due to insulin deficiency that affects 10% of the 
population worldwide. The number of diabetic 
people is expected to rise from present estimate 
of 150 million to 230 million in 2025 [1]. 
Impaired glucose tolerance and the metabolic 
syndrome often lead to development of type 2 
diabetes. A number of important epidemiological  
 
studies have highlighted the relationship between 
hyperglycemia and an increased risk of 
cardiovascular disease. The risk of cardiovascular 
disease is increased threefold in patients with 
established diabetes. Micro- and macro vascular 
disease can be traced back to hyperglycemia and 
the metabolic syndrome [2]. 
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The detrimental effects of diabetic complications 
are mainly mediated and complicated through 
oxidative stress [3]. Diabetes is usually associated 
by increased production of the molecules of 
reactive oxygen species (ROS) and/or impaired 
antioxidant defense systems, which result 
oxidative damage leading to ROS mediated 
diabetic pathogenesis [4]. Although numerous 
synthetic drugs were developed to combat against 
diabetes but the situation has only marginally 
improved. Many natural products have been used 
successfully since ancient era to counteract 
diabetes and its associated complications [5]. 
Natural products are being prescribed widely 
considering their safety, effectiveness, and 
availability [6]. Furthermore, after the 
recommendation made by WHO on diabetes 
mellitus, investigation on hypoglycemic agent 
from medicinal plants has been more important 
from researcher’s viewpoint [7]. Natural 
antioxidant compounds have been found fruitful 
against diabetes and associated complication [8]. 
So, it is worthy to develop a natural lead with a 
stirring prospect for the expansion of an 
alternative way of treatment of diabetes. 
Mimusops elengi (ME) Linn (Sapotaceae) 
commonly known as Bakul, is a small to large 
evergreen tree found all over the different parts of 
India. It is cultivated in gardens as an ornamental 
tree. Earlier report revealed that the fruits are 
used in chronic dysentery, constipations; flowers 
are used as snuff to relive headache, lotion for 
wounds and ulcers. Barks are used to increase 
fertility in women and known to have antiulcer 
activity [9]. Bark is used as a tonic [10, 11], 
febrifuge, as a gargle for odontopathy, 
inflammation and bleeding of gums [9]. 
Mimusops elengi is a rich source of tannin, 
saponin, alkaloids and glycosides [12]. 
Sushrut Samhita [13] in the Chikitsa chapter 
explains the treatment strategies for the diabetes. 
Mimusops elengi is endowed with the antidiabetic 
potential.  
The present study was aimed to evaluate the in 
vitro antioxidant and antihyperglycemic property 
of Methanolic extract of bark of ME (MEMeOH). 
 
Materials and methods 
Collection and authentication of plant 
material 
Mimusops elengi bark was collected during May 
and June from Rajgurunagar, Pune District, 
Maharashtra State, India. The plant was identified 
and authenticated by Botanical Survey of India 
and a voucher specimen was deposited at 
Botanical Survey of India (voucher specimen 
sample no. GG 01).  
 
Drugs and chemicals 
Glyburide (Ranbaxy Pharma Ltd., India), alloxan 
monohydrate (Spectrochem, India), glucose 
estimation kit (Accurex Biomedical Pvt.Ltd.), 
India, were purchased from respective vendors. 
 
Preparation of methanolic extract of 
Mimusops elengi (MEMeOH) 
The stem bark of Mimusops elengi was shade-
dried and powdered in a grinder. The powdered 
material (100 g) was extracted with methanol 
using soxhlet extraction at 40oC. The extract was 
dried on a tray dryer at 40◦C (yield – 10.2 % 
w/w). The extract was suspended in 1% w/v 
CMC and used for pharmacological studies. 
 
In vitro antioxidant activity Sample 
preparation  
100 µg/ml stock solutions were prepared by 
dissolving 5 mg of test compound and ascorbic 
acid to 50 ml with distilled water. Different 
concentrations of test and ascorbic acid like 10, 
25, 50 and 100 µg/ml were prepared from stock 
solution. 
 
Ferric ion reducing antioxidant power (FRAP) 
[14] 
1ml of different concentrations of test and 
ascorbic acid as a standard compounds were 
mixed with 2.5 ml of phosphate buffer and 2.5 ml 
of potassium ferricyanide. The mixture was 
incubated at 500C for 20 min. 2.5 ml of tri chloro 
acetic acid (TCA) was added to the mixture, 
which was then centrifuged at 3000 g for 10 min. 
2.5 ml of upper layer solution was taken and 
mixed with 2.5 ml distilled water and 0.5 ml of 
FeCl3 solution and the absorbance was measured 
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at 700 nm. Increased absorbance of the reaction 
mixture indicated increased reducing power. 
 
Free radical scavenging activity by DPPH 
method [15] 
1ml of different concentration of test and 
standard were employed in different test tubes. 
To this 5 ml of methanolic solution of DPPH was 
added, shaken well and incubated at 370C for 20 
min. The absorbance was measured against 
methanol as blank at 517 nm.  
 
Hydroxyl radical scavenging activity assay 
[14] 
The scavenging activity for hydroxyl radicals was 
measured with Fenton reaction. Reaction mixture 
contained 60 μl of 1.0mM FeCl3, 90 μl of 1mM 
1,10- phenanthroline, 2.4 ml of 0.2 M phosphate 
buffer (pH 7.8), 150 μl of 0.17 M H2O2, and 1.5 
ml of test compounds and standard at various 
concentrations. Adding H2O2 started the reaction. 
After incubation at room temperature for 5 min, 
the absorbance of the mixture at 560nm was 
measured with a spectrophotometer. 
 
Experimental animals  
Swiss albino mice (25–30 g) of either sex were 
obtained from Serum Institute of India, Pune, 
India. Animals were maintained at a temperature 
of 25±1 ◦C and relative humidity of 45–55% 
under 12-h light: 12-h dark cycle. The animals 
had free access to food pellets (Chakan Oil Mills, 
Pune, India) and water was available ad libitum.  
 
Acute oral toxicity studies 
Adult albino mice of either sex were subjected to 
acute toxicity studies as per guideline (425) 
suggested by Organization for Economic Co-
operation and Development (OECD). The mice 
were observed for 2 h for behavioral, 
neurological and autonomic profiles and for any 
lethality during next 48 h. 
 
Induction of experimental diabetes and 
determination of serum glucose level 
Diabetes was induced in Swiss albino mice by a 
single intravenous injection of aqueous alloxan 
monohydrate (80 mg/ kg, i.v.) solution in normal 
saline. After 48 h, the animals showing serum 
glucose level above 300mg/dl were selected for 
the study. 
 
Effect of acute administration of MEMeOH in 
alloxan induced diabetes in mice [16] 
Diabetic Swiss albino mice of either sex were 
divided into different groups (n=6) viz; Group I, 
vehicle (1% w/v CMC; 10ml/kg, p.o.); Group II, 
glyburide (10mg/kg, p.o.); Group III, MEMeOH 
(100 mg/kg, p.o.), Group IV, MEMeOH (200 
mg/kg, p.o.) and Group V, MEMeOH (400 
mg/kg, p.o.). Acute study involved determination 
of serum glucose level at 0, 2, 4, 6 and 24 hr after 
glyburide and MEMeOH administration.  
 
Antihyperglycemic activity 
Effect of MEMeOH on oral glucose tolerance test 
(OGTT) in non- diabetic mice. 
The non diabetic mice were fasted overnight 
before the experiment. The animals were divided 
into different groups (n = 6): group I - vehicle 
(CMC 1%, 10 ml/kg, p. o.), group II - glyburide 
(10 mg/kg, p.o.), group III, IV and V – 
MEMeOH (100, 200 and 400 mg/kg, p.o.) 
respectively. D-Glucose (2.5 g/kg, p.o.) was 
administered 0.5 hr of pretreatment with 
glyburide or MEMeOH. Serum glucose levels 
were estimated at 30, 60, and 120 min after 
glucose loading through retro orbital plexus. 
Serum glucose level is estimated using GOD-
POD method.  
Effect of MEMeOH on oral glucose tolerance test 
(OGTT) in diabetic mice. 
The diabetic mice were fasted overnight before 
the experiment. The animals were divided into 
different groups (n = 6): group I - vehicle (CMC 
1%, 10 ml/kg, p. o.), group II - glyburide (10 
mg/kg, p.o.), group III, IV and V – MEMeOH 
(100, 200 and 400 mg/kg, p.o.) respectively. D-
Glucose (2.5 g/kg, p.o.) was administered in 
diabetic mice at the 4th hr of pretreatment with 
glyburide or MEMeOH. Serum glucose levels 
were estimated before and 2 hr after glucose 
loading in diabetic mice using GOD-POD 
method.  
Statistical analysis 
Data was expressed as mean ± SEM and 
statistical analysis was carried out by one-way 
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ANOVA with post hoc Dunnett’s test performed 
using Graph Pad InStat. P value was considered 
significant when P < 0.05. 
 
Results 
The reducing power of MEMeOH displayed a 
concentration-dependent antioxidant activity 
there was increase in the absorbance with 
increase in concentration (Fig. 1). 
 
 
 
Fig. 1: Effect of MEMeOH on in vitro Reducing Power Assay 
 
It was observed that MEMeOH scavenged the 
DPPH radical in concentration dependent 
manner. The percent scavenging of DPPH radical 
by MEMeOH and ascorbic acid at 100µg/ml 
concentration were found to be 71.55 and 77.23 
respectively (Table 1). 
Hydroxyl radical scavenging activity assay 
exhibited the potential of MEMeOH in 
scavenging hydroxyl free radical in concentration 
dependent manner. The percent scavenging of 
hydroxyl radical by MEMeOH and ascorbic acid 
were found to be 82.11 and 93.91 respectively 
(Table 1). 
 
Table 1: In vitro DPPH and hydroxyl radical cavenging 
activity of MEMeOH. 
 
% DPPH scavenging % hydroxyl scavenging Conc. 
(μg/ 
ml) MEMeOH 
Ascorbic 
acid MEMeOH 
Ascorbic 
acid 
10 42.55±3.12 62.50±3.04 31.44± 1.12 41.23± 2.34 
25 53.06±2.77 69.12±5.12 49.99± 2.11 62.34± 2.77 
50 64.12±5.17 72.87±4.24 68.88± 2.86 83.11±6.01 
100 71.55±3.22 77.23±3.32 82.11± 4.20 93.91± 6.11 
 
Acute oral toxicity studies 
Acute toxicity studies revealed that MEMeOH 
was found safe up to a dose level of 5000 mg/kg, 
p.o. in mice. No lethality or any toxic reactions 
were observed up to the end of the study period. 
LD50 of MEMeOH is found to be > 5000mg/ kg, 
p.o. 
 
Effect of MEMeOH on serum glucose in 
alloxan induced diabetic mice 
Single dose administration of MEMeOH 100 
mg/kg, p.o. significantly reduced the serum 
glucose level at 2nd hr. of administration. 
MEMeOH produced highest activity at 6th and 
the onset of activity was 2nd hr. The onset of 
antihyperglycemic effect of MEMeOH 100, 200, 
400mg/kg and glyburide (10mg/kg, p.o.) was 
observed at 2nd hr; peak antihyperglycemic effect 
was demonstrated at 6th hr. The 
antihyperglycemic effect of MEMeOH 400mg/kg 
was persistent up to 24th hr. after drug 
administration (Fig. 2).  
 
 
 
Fig. 2: Effect of MEMeOH on serum glucose in alloxan 
induced diabetic mice 
 
Effect of MEMeOH on oral glucose tolerance 
test (OGTT) in diabetic mice 
 
At 6th hr. of administration; glyburide (10mg/kg, 
p.o.) and MEMeOH 100, 200 and 400 mg/kg, 
p.o. produced significant (p < 0.01) reduction in 
elevated glucose level. Glyburide (10mg/kg, p.o.) 
and MEMeOH 100, 200 and 400 mg/kg, p.o. 
produced significant (p < 0.01) reduction in 
elevated glucose level 2 hr. before administration 
of glucose load (Fig. 3). 
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Fig. 3: Effect of MEMeOH on oral glucose tolerance test 
(OGTT) in diabetic mice 
 
Effect of MEMeOH on oral glucose tolerance 
test (OGTT) in non diabetic mice 
 
Glyburide (10mg/kg, p.o.) and MEMeOH 200, 
400 mg/kg, p.o. produced significant (p < 0.01) 
reduction in elevated glucose levels at 120 min 
after oral glucose load. MEMeOH 200 mg/kg, 
p.o. demonstrated significant (p < 0.05) reduction 
in serum glucose level at 60 min. MEMeOH 400 
mg/kg, p.o. demonstrated significant (p < 0.001) 
reduction in serum glucose level at 60 min. 
MEMeOH 100 mg/kg, p.o. demonstrated 
significant (p < 0.05) reduction in serum glucose 
level at 120 min (Fig. 4). 
 
 
 
Fig. 4: Effect of MEMeOH on oral glucose tolerance test 
(OGTT) in non diabetic mice 
 
Discussion 
 
Oxidative stress induced due to enhanced 
generation of reactive oxygen species (ROS) has 
been implicated in the etiology of diabetes. 
Antioxidants that can scavenge these reactive 
oxygen species or neutralize these radicals are 
beneficial in reducing this oxidative stress. In this 
context natural components with antioxidant 
activities are very important [17]. Reactive 
oxygen species play an important role in the 
development of diabetes and mainly in further 
complications of diabetes [18]. Oxidative stress is 
believed to be a common pathway linking diverse 
mechanisms for the pathogenesis of 
complications of diabetes. There is strong 
evidence for increased levels of indicators of 
oxidative stress in diabetic individuals suffering 
from complications [19]. 
The potential of the antioxidant constituents of 
plant materials for the maintenance of health and 
protection from coronary heart disease and 
diabetes is raising interest among scientists [20, 
21]. Antioxidants are compounds that can delay 
or inhibit the oxidation of lipids or other 
molecules by inhibiting the initiation or 
propagation of oxidative chain reactions [22]. 
The antioxidant activity of natural compounds is 
mainly due to their redox properties [23], which 
can play an important role in absorbing and 
neutralizing free radicals, quenching singlet and 
triplet oxygen, or decomposing peroxides [24]. 
Therefore, use of antioxidants is reasonable in 
cure of diabetes and an antidiabetic drug with 
antioxidant potential will have a dual advantage. 
We have evaluated in vitro antioxidant potential 
of MEMeOH in the present investigation. 
A reducing power is an indicative of a reducing 
agent having the availability of atoms which can 
donate electrons and react with free radicals, and 
then convert them into more stable metabolites 
and terminate the radical chain reaction. From the 
present investigation it is very clear that 
MEMeOH has concentration dependent reducing 
ability which could possibly be one of the modes 
of its antioxidant activity.  
DPPH is a stable free radical that accepts an 
electron or hydrogen radical to become a stable 
diamagnetic molecule. The method of scavenging 
the stable DPPH radical is widely used for 
relatively rapid evaluation of antioxidant activity 
compared to other methods. The reduction of the 
DPPH radical is determined by its decrease in 
absorbance at 517 nm. The extent of reduction of 
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DPPH free radical is visualized as a discoloration 
from purple to yellow [25]. The present 
investigation indicated that MEMeOH has radical 
scavenging capacity. 
The highly reactive oxygenated radical is 
assumed to attack cellular molecules including 
hepatic tissue, because it is located less than a 
few nanometers from the site of their generation 
[26]. For experimental purposes, ·OH is being 
produced by the reaction of transition metal ions 
including iron and copper with H2O2, ultraviolet 
(UV) photolysis, and the electro catalysis of 
H2O2, namely photo-Fenton and electro-Fenton 
reactions, respectively [27]. In the present work, 
we focused on the scavenging activity of ·OH to 
evaluate the antioxidant activity of MEMeOH 
because ·OH is biologically available radical and 
has the role to play in the pathogenesis of 
different diseases. Scavenging ability of 
MEMeOH reflected potential use of antioxidant 
mechanism of MEMeOH in diabetes and related 
complications. 
Alloxan, induces “chemical diabetes” in a wide 
variety of animal species by damaging the insulin 
secreting cells of the pancreas. This damages a 
large number of β cells, resulting in a decrease in 
endogenous insulin release, which paves the ways 
for the decreased use of glucose by the tissues 
[28]. Our study showed that alloxan-induced 
diabetic mice presented obvious hyperglycemic 
symptoms and significant injury in islets. The 
administration of MEMeOH significantly 
decreased serum glucose which could be treating 
the early clinical symptom of diabetes i.e. 
hyperglycemia. These results suggested that 
MEMeOH has a protective action in the 
hyperglycemic conditions of diabetes mellitus. 
In the present study, alloxan injection produced 
significant hyperglycemia in all the test animals. 
The MEMeOH showed peak antihyperglycemic 
effect at 6 hr. The onset of antihyperglycemic 
activity was at 2nd after alloxan administration. 
The effect was persistent up to 24 hr.  
Diabetic animals have impaired glucose 
tolerance. Additional load of glucose was found 
to impair the tolerance further. As acute study 
with alloxan revealed that the peak 
antihyperglycemic action is at 6th; the OGTT 
experiment was designed in such a way that 
glucose load was administered at 4th hr after 
pretreatment with MEMeOH and serum glucose 
was determined 2nd hr after glucose load. 
MEMeOH produced significant reduction in 
elevated blood glucose levels before glucose load 
and after glucose load in diabetic animals. It can 
be concluded that MEMeOH may act by 
increasing peripheral utilization of glucose. 
Glyburide (10mg/kg) was more effective in 
showing antihyperglycemic effect as well as 
glucose tolerance. 
Non diabetic OGTT revealed that MEMeOH 
demonstrated significant lowering of elevated 
glucose level in glucose loaded animals. The 
onset of action was found to be 60 min and 
duration of action was longer than 2hr. 
 
Conclusion 
 
Taking into consideration the traditional claim of 
ME as having antioxidant and antihyperglycemic 
potential, MEMeOH has demonstrated 
antihyperglycemic activity in diabetic as well as 
non diabetic glucose loaded mice. MEMeOH 
should be further explored against diabetes and 
related complications. 
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